Bao L - Search Results

1

Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo.

Deng W, Xu Y, Kong Q, Xue J, Yu P, Liu J, Lv Q, Li F, Wei Q, Bao L. Deng W, et al. Among authors: bao l. Signal Transduct Target Ther. 2020 May 8;5(1):66. doi: 10.1038/s41392-020-0176-0. Signal Transduct Target Ther. 2020. PMID: 32385228 Free PMC article. No abstract available.

2

[Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray on SARS-CoV infection in Macaca mulata].

Gao H, Zhang LL, Wei Q, Duan ZJ, Tu XM, Yu ZA, Deng W, Zhang LP, Bao LL, Zhang B, Tong W, Hou YD, Zhang BL, Huang L, Qin C. Gao H, et al. Among authors: bao ll. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep;19(3):207-10. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005. PMID: 16261198 Chinese.

3

Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China.

Bao L, Vidal N, Fang H, Deng W, Chen S, Guo W, Qin C, Peeters M, Delaporte E, Andrieu JM, Lu W. Bao L, et al. AIDS Res Hum Retroviruses. 2008 May;24(5):733-42. doi: 10.1089/aid.2007.0269. AIDS Res Hum Retroviruses. 2008. PMID: 18462079

4

Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China.

Deng W, Fu P, Bao L, Vidal N, He Q, Qin C, Peeters M, Delaporte E, Andrieu JM, Lu W. Deng W, et al. Among authors: bao l. AIDS. 2009 May 15;23(8):977-85. doi: 10.1097/QAD.0b013e328329217d. AIDS. 2009. PMID: 19359980

5

Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals.

Bao L, Xu L, Zhan L, Deng W, Zhu H, Gao H, Sun H, Ma C, Lv Q, Li F, Chen H, Zhang L, Qin C. Bao L, et al. Virus Res. 2010 Jul;151(1):60-5. doi: 10.1016/j.virusres.2010.03.019. Epub 2010 Apr 8. Virus Res. 2010. PMID: 20381552

6

A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo.

Xu L, Bao L, Lv Q, Deng W, Ma Y, Li F, Zhan L, Zhu H, Ma C, Qin C. Xu L, et al. Among authors: bao l. Virol J. 2010 Nov 18;7:325. doi: 10.1186/1743-422X-7-325. Virol J. 2010. PMID: 21083933 Free PMC article.

7

Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice.

Meng S, Liu Z, Xu L, Li L, Mei S, Bao L, Deng W, Li L, Lei R, Xie L, Qin C, Zhang L. Meng S, et al. Among authors: bao l. PLoS One. 2011;6(5):e19863. doi: 10.1371/journal.pone.0019863. Epub 2011 May 20. PLoS One. 2011. PMID: 21625486 Free PMC article.

8

Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo.

Xu L, Bao L, Zhou J, Wang D, Deng W, Lv Q, Ma Y, Li F, Sun H, Zhan L, Zhu H, Ma C, Shu Y, Qin C. Xu L, et al. Among authors: bao l. PLoS One. 2011;6(6):e20698. doi: 10.1371/journal.pone.0020698. Epub 2011 Jun 15. PLoS One. 2011. PMID: 21698272 Free PMC article.

9

Highly pathogenic avian influenza H5N1 virus could partly be evacuated by pregnant BALB/c mouse during abortion or preterm delivery.

Xu L, Bao L, Deng W, Qin C. Xu L, et al. Among authors: bao l. Virol J. 2011 Jul 8;8:342. doi: 10.1186/1743-422X-8-342. Virol J. 2011. PMID: 21740553 Free PMC article.

10

Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic.

An SC, Xu LL, Li FD, Bao LL, Qin C, Gao ZC. An SC, et al. Med Hypotheses. 2011 Dec;77(6):1054-7. doi: 10.1016/j.mehy.2011.09.001. Epub 2011 Sep 25. Med Hypotheses. 2011. PMID: 21944947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,018 results

Search Page

Filters